Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 2,813 | 2,676 | 1,972 | 3,260 | 3,150 |
| Cost of Goods | 514 | 491 | 345 | 495 | 613 |
| Gross Profit | 2,299 | 2,185 | 1,627 | 2,765 | 2,537 |
| Operating Expenses | 11,600 | 10,778 | 11,817 | 9,546 | 13,046 |
| Operating Income | -8,787 | -8,102 | -9,845 | -6,286 | -9,896 |
| Interest Expense | 500 | 3,453 | 2,181 | 3,262 | 2,731 |
| Other Income | 1,383 | -736 | -371 | 1,316 | 18 |
| Pre-tax Income | -7,904 | -12,291 | -12,397 | -8,232 | -12,609 |
| Net Income Continuous | -7,904 | -12,291 | -12,397 | -8,232 | -12,609 |
| Minority Interests | -126 | -141 | -195 | -651 | -89 |
| Net Income | $-7,778 | $-12,150 | $-12,202 | $-7,581 | $-12,520 |
| EPS Basic Total Ops | -19,667.83 | -36,145.11 | -125,853.10 | 238,015.10 | -464,971.80 |
| EPS Basic Continuous Ops | -19,988.29 | -36,543.81 | -127,750.20 | 215,917.30 | -468,189.50 |
| EPS Diluted Total Ops | -19,667.83 | -36,145.11 | -125,853.10 | 238,015.10 | -464,971.80 |
| EPS Diluted Continuous Ops | -19,988.29 | -36,543.81 | -127,750.20 | 215,917.30 | -468,189.50 |
| EBITDA(a) | $-1,075 | $-4,348 | $-8,018 | $-2,717 | $-6,781 |